Literature DB >> 23427151

Genetic screen of a library of chimeric poxviruses identifies an ankyrin repeat protein involved in resistance to the avian type I interferon response.

Karen Buttigieg1, Stephen M Laidlaw, Craig Ross, Marc Davies, Stephen Goodbourn, Michael A Skinner.   

Abstract

Viruses must be able to resist host innate responses, especially the type I interferon (IFN) response. They do so by preventing the induction or activity of IFN and/or by resisting the antiviral effectors that it induces. Poxviruses are no exception, with many mechanisms identified whereby mammalian poxviruses, notably, vaccinia virus (VACV), but also cowpox and myxoma viruses, are able to evade host IFN responses. Similar mechanisms have not been described for avian poxviruses (avipoxviruses). Restricted for permissive replication to avian hosts, they have received less attention; moreover, the avian host responses are less well characterized. We show that the prototypic avipoxvirus, fowlpox virus (FWPV), is highly resistant to the antiviral effects of avian IFN. A gain-of-function genetic screen identified fpv014 to contribute to increased resistance to exogenous recombinant chicken alpha IFN (ChIFN1). fpv014 is a member of the large family of poxvirus (especially avipoxvirus) genes that encode proteins containing N-terminal ankyrin repeats (ANKs) and C-terminal F-box-like motifs. By binding the Skp1/cullin-1 complex, the F box in such proteins appears to target ligands bound by the ANKs for ubiquitination. Mass spectrometry and immunoblotting demonstrated that tandem affinity-purified, tagged fpv014 was complexed with chicken cullin-1 and Skp1. Prior infection with an fpv014-knockout mutant of FWPV still blocked transfected poly(I·C)-mediated induction of the beta IFN (ChIFN2) promoter as effectively as parental FWPV, but the mutant was more sensitive to exogenous ChIFN1. Therefore, unlike the related protein fpv012, fpv014 does not contribute to the FWPV block to induction of ChIFN2 but does confer resistance to an established antiviral state.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23427151      PMCID: PMC3624283          DOI: 10.1128/JVI.02738-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  Differential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein.

Authors:  Paul Potter; Sophie Tourdot; Tom Blanchard; Geoffrey L Smith; Keith G Gould
Journal:  J Gen Virol       Date:  2001-05       Impact factor: 3.891

2.  Genome of horsepox virus.

Authors:  E R Tulman; G Delhon; C L Afonso; Z Lu; L Zsak; N T Sandybaev; U Z Kerembekova; V L Zaitsev; G F Kutish; D L Rock
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 3.  Pathogen subversion of cell-intrinsic innate immunity.

Authors:  Craig R Roy; Edward S Mocarski
Journal:  Nat Immunol       Date:  2007-11       Impact factor: 25.606

4.  Identification and characterization of three immunodominant structural proteins of fowlpox virus.

Authors:  Denise Boulanger; Philip Green; Brenda Jones; Gwenn Henriquet; Lawrence G Hunt; Stephen M Laidlaw; Paul Monaghan; Michael A Skinner
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

5.  Poxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-kappaB activation by tumor necrosis factor alpha but is independent of its host range function.

Authors:  Shu-Jung Chang; Jye-Chian Hsiao; Stephanie Sonnberg; Cheng-Ting Chiang; Min-Hsiang Yang; Der-Lii Tzou; Andrew A Mercer; Wen Chang
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

6.  MNF, an ankyrin repeat protein of myxoma virus, is part of a native cellular SCF complex during viral infection.

Authors:  Sophie Blanié; Jacqueline Gelfi; Stéphane Bertagnoli; Christelle Camus-Bouclainville
Journal:  Virol J       Date:  2010-03-08       Impact factor: 4.099

7.  The highly conserved orthopoxvirus 68k ankyrin-like protein is part of a cellular SCF ubiquitin ligase complex.

Authors:  Karin M Sperling; Astrid Schwantes; Barbara S Schnierle; Gerd Sutter
Journal:  Virology       Date:  2008-03-18       Impact factor: 3.616

8.  The genome of canarypox virus.

Authors:  E R Tulman; C L Afonso; Z Lu; L Zsak; G F Kutish; D L Rock
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  Integrin alpha 7 as substrate for a glycosylphosphatidylinositol-anchored ADP-ribosyltransferase on the surface of skeletal muscle cells.

Authors:  A Zolkiewska; J Moss
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

10.  Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein.

Authors:  Samantha Cooray; Mohammad W Bahar; Nicola G A Abrescia; Colin E McVey; Nathan W Bartlett; Ron A-J Chen; David I Stuart; Jonathan M Grimes; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2007-06       Impact factor: 3.891

View more
  10 in total

1.  Chlorovirus Skp1-binding ankyrin repeat protein interplay and mimicry of cellular ubiquitin ligase machinery.

Authors:  Eric A Noel; Ming Kang; Jiri Adamec; James L Van Etten; George A Oyler
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

2.  Murine norovirus: propagation, quantification, and genetic manipulation.

Authors:  Seungmin Hwang; Bader Alhatlani; Armando Arias; Sarah L Caddy; Constantina Christodoulou; Juliana Bragazza Cunha; Ed Emmott; Marta Gonzalez-Hernandez; Abimbola Kolawole; Jia Lu; Christine Rippinger; Frédéric Sorgeloos; Lucy Thorne; Surender Vashist; Ian Goodfellow; Christiane E Wobus
Journal:  Curr Protoc Microbiol       Date:  2014-05-01

3.  Genetic screen of a mutant poxvirus library identifies an ankyrin repeat protein involved in blocking induction of avian type I interferon.

Authors:  Stephen M Laidlaw; Rebecca Robey; Marc Davies; Efstathios S Giotis; Craig Ross; Karen Buttigieg; Stephen Goodbourn; Michael A Skinner
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

4.  Construction of FWPV Chimaeric MVA.

Authors:  Karen R Buttigieg; Michael A Skinner
Journal:  Bio Protoc       Date:  2015-01-05

Review 5.  Poxviral ankyrin proteins.

Authors:  Michael H Herbert; Christopher J Squire; Andrew A Mercer
Journal:  Viruses       Date:  2015-02-16       Impact factor: 5.048

6.  Chicken interferome: avian interferon-stimulated genes identified by microarray and RNA-seq of primary chick embryo fibroblasts treated with a chicken type I interferon (IFN-α).

Authors:  Efstathios S Giotis; Rebecca C Robey; Natalie G Skinner; Christopher D Tomlinson; Stephen Goodbourn; Michael A Skinner
Journal:  Vet Res       Date:  2016-08-05       Impact factor: 3.683

7.  Recombinant fowlpox virus vector-based vaccines: expression kinetics, dissemination and safety profile following intranasal delivery.

Authors:  David G Townsend; Shubhanshi Trivedi; Ronald J Jackson; Charani Ranasinghe
Journal:  J Gen Virol       Date:  2017-04-01       Impact factor: 3.891

8.  Constitutively elevated levels of SOCS1 suppress innate responses in DF-1 immortalised chicken fibroblast cells.

Authors:  E S Giotis; C S Ross; R C Robey; A Nohturfft; S Goodbourn; M A Skinner
Journal:  Sci Rep       Date:  2017-12-13       Impact factor: 4.379

9.  Chicken Embryonic-Stem Cells Are Permissive to Poxvirus Recombinant Vaccine Vectors.

Authors:  Efstathios S Giotis; Guillaume Montillet; Bertrand Pain; Michael A Skinner
Journal:  Genes (Basel)       Date:  2019-03-20       Impact factor: 4.141

10.  Modulation of Early Host Innate Immune Response by an Avipox Vaccine Virus' Lateral Body Protein.

Authors:  Efstathios S Giotis; Stephen M Laidlaw; Susanna R Bidgood; David Albrecht; Jemima J Burden; Rebecca C Robey; Jason Mercer; Michael A Skinner
Journal:  Biomedicines       Date:  2020-12-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.